Bruce & Co., Inc.
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 9, 2024), Bruce & Co., Inc. reported 38 stock positions worth $299.2 million. Its top holding was U-Haul Holding Co.-Non Voting (UHAL.B) at 10.9% of the portfolio, followed by Merck (MRK, 9.3%) and Abbvie (ABBV, 9.3%). Compared with Q1 2024, it opened 1 new position, added to 22 and reduced 1. The biggest buy was Nextera Energy (shares +14%) and the biggest sale Valeant Pharmaceuticals Intl (shares −15%).
- Most Recent 13F
- Q2 2026
- Location
- CHICAGO, IL
- CIK
- 0001358331
- Portfolio Value
- $299.2M (Q2 2024)
- SEC Filing
- 0001104659-24-087704 ↗ filed Aug 9, 2024
Holdings Value
Holdings 38 stocks · $299.2M
| UHAL.B U-Haul Holding Co.-Non Voting | 10.89% | 542,950 | $32.6M | Add +10.1% |
| MRK Merck & Co Inc | 9.29% | 224,500 | $27.8M | Add +1.7% |
| ABBV Abbvie Inc. | 9.26% | 161,500 | $27.7M | Add +17.0% |
| Nextera Energy filed as FPL GROUP INC | 7.89% | 333,300 | $23.6M | Add +13.5% |
| ALL Allstate Corp. | 6.96% | 130,500 | $20.8M | Add +2.6% |
| DUK Duke Energy Corp. | 6.89% | 205,816 | $20.6M | Add +0.9% |
| CMS CMS Energy Corp. | 6.37% | 320,000 | $19.0M | Add +1.3% |
| T AT&T Inc. | 6.29% | 984,000 | $18.8M | Add +2.4% |
| ABT Abbott Laboratories | 5.29% | 152,300 | $15.8M | Add +1.5% |
| IIIN Insteel Industries Inc. | 3.55% | 343,423 | $10.6M | No change |
| XEL Xcel Energy Inc. | 3.50% | 196,000 | $10.5M | Add +1.6% |
| AAPL Apple Inc. | 2.79% | 39,700 | $8.4M | Add +13.1% |
| PFE Pfizer Inc. | 2.58% | 276,400 | $7.7M | Add +2.9% |
| AVA Avista Corp. | 2.33% | 201,500 | $7.0M | No change |
| DAR Darling Ingredients Inc. | 1.84% | 150,000 | $5.5M | No change |
| BG Bunge Global SA | 1.78% | 50,000 | $5.3M | No change |
| UHAL U-Haul Holding Co. | 1.55% | 75,105 | $4.6M | Add +6.1% |
| NEM Newmont Corp. | 1.40% | 100,000 | $4.2M | Add +52.4% |
| VALEANT PHARMACEUTICALS INTL filed as Bausch Health | 1.28% | 550,000 | $3.8M | Reduce -14.6% |
| RLI Rli Corp. | 1.05% | 22,400 | $3.2M | Add +1020.0% |
| ADM Archer-Daniels-Midland Co. | 1.01% | 50,000 | $3.0M | No change |
| FOCL Edap TMS SA -ADR | 1.01% | 553,652 | $3.0M | No change |
| VICR Vicor Corp. | 0.78% | 70,000 | $2.3M | Add +55.6% |
| SUPN Supernus Pharmaceuticals Inc. | 0.73% | 82,105 | $2.2M | No change |
| SIRI Sirius XM Holdings Inc. | 0.53% | 557,843 | $1.6M | No change |
| ASH Ashland LLC | 0.47% | 15,000 | $1.4M | No change |
| LVTX Lava Therapeutics NV | 0.46% | 771,874 | $1.4M | No change |
| MNKD Mannkind Corp. | 0.34% | 195,073 | $1.0M | No change |
| KOD Kodiak Sciences Inc. | 0.33% | 423,000 | $994K | No change |
| FATE Fate Therapeutics Inc. | 0.33% | 300,000 | $984K | Add +109.8% |
| IGMS Igm Biosciences Inc. | 0.23% | 100,000 | $687K | Add +53.9% |
| OGN Organon & Co. | 0.22% | 31,370 | $649K | Add +0.6% |
| VTRS Viatris Inc. | 0.21% | 58,833 | $625K | Add +1.0% |
| CRBU Caribou Biosciences Inc. | 0.16% | 300,000 | $492K | Add +50.0% |
| WEC WEC Energy Group Inc. | 0.12% | 4,509 | $354K | New |
| MASS 908 Devices Inc. | 0.12% | 68,286 | $352K | No change |
| PSNL Personalis Inc. | 0.12% | 300,000 | $351K | No change |
| WBD Warner Bros Discovery Inc. | 0.03% | 11,851 | $88K | Add +11.4% |
Other holdings (2): bonds, preferreds, convertibles and warrants · $4.8M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| Acorda Theraputics | Cv 6.0% · principal | 5,000,000 | $3.5M | No change |
| ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26) | NOTE 5.000%12/1 · principal | 3,212,268 | $1.3M | Add +2.5% |
Total filed on the 13F, all lines: $304.0M.
Portfolio Sells Q1 2024 → Q2 2024
| VALEANT PHARMACEUTICALS INTL | Reduce -14.6% | 1.28% | −1.02 |
Portfolio Buys Q1 2024 → Q2 2024
| Nextera Energy | Add +13.5% | 7.89% | +1.57 |
| RLI Rli Corp. | Add +1020.0% | 1.05% | +0.95 |
| ABBV Abbvie Inc. | Add +17.0% | 9.26% | +0.80 |
| AAPL Apple Inc. | Add +13.1% | 2.79% | +0.77 |
| NEM Newmont Corp. | Add +52.4% | 1.40% | +0.61 |
| T AT&T Inc. | Add +2.4% | 6.29% | +0.59 |
| DUK Duke Energy Corp. | Add +0.9% | 6.89% | +0.26 |
| VICR Vicor Corp. | Add +55.6% | 0.78% | +0.20 |
| WEC WEC Energy Group Inc. | New | 0.12% | +0.12 |
| PFE Pfizer Inc. | Add +2.9% | 2.58% | +0.08 |
| OGN Organon & Co. | Add +0.6% | 0.22% | +0.02 |
| IGMS Igm Biosciences Inc. | Add +53.9% | 0.23% | +0.02 |
| XEL Xcel Energy Inc. | Add +1.6% | 3.50% | +0.01 |
| WBD Warner Bros Discovery Inc. | Add +11.4% | 0.03% | −0.00 |
| FATE Fate Therapeutics Inc. | Add +109.8% | 0.33% | −0.02 |
| VTRS Viatris Inc. | Add +1.0% | 0.21% | −0.03 |
| CMS CMS Energy Corp. | Add +1.3% | 6.37% | −0.05 |
| UHAL U-Haul Holding Co. | Add +6.1% | 1.55% | −0.06 |
| UHAL.B U-Haul Holding Co.-Non Voting | Add +10.1% | 10.89% | −0.18 |
| CRBU Caribou Biosciences Inc. | Add +50.0% | 0.16% | −0.18 |
| ALL Allstate Corp. | Add +2.6% | 6.96% | −0.44 |
| ABT Abbott Laboratories | Add +1.5% | 5.29% | −0.45 |
| MRK Merck & Co Inc | Add +1.7% | 9.29% | −0.51 |
Notes & Other Activity Q1 2024 → Q2 2024
| ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26) | NOTE 5.000%12/1 · principal | Add +2.5% | 3,212,268 | $1.3M |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 41 | $369.5M | ABBV, ALL, AER, Nextera Energy, MRK |
| Q1 2026 | 41 | $349.7M | Nextera Energy, ABBV, ALL, AER, MRK |
| Q4 2025 | 39 | $322.5M | ABBV, AER, ALL, Nextera Energy, UHAL.B |
| Q3 2025 | 39 | $322.9M | ABBV, ALL, Nextera Energy, UHAL.B, AER |
| Q2 2025 | 40 | $307.8M | ALL, UHAL.B, ABBV, Nextera Energy, AER |
| Q1 2025 | 41 | $310.5M | UHAL.B, ABBV, ALL, Nextera Energy, DUK |
| Q4 2024 | 39 | $309.9M | UHAL.B, ALL, ABBV, Nextera Energy, MRK |
| Q3 2024 | 39 | $342.1M | UHAL.B, ABBV, Nextera Energy, ALL, MRK |
| Q2 2024 | 38 | $299.2M | UHAL.B, MRK, ABBV, Nextera Energy, ALL |
| Q1 2024 | 37 | $297.1M | UHAL.B, MRK, ABBV, ALL, DUK |